Evaluation of [ 18 F]2FP3 in pigs and non-human primates.

So far, no suitable 5-HT7 R radioligand exists for clinical PET imaging. [18 F]2FP3 was first tested in vivo in cats and the results were promising for further evaluations. Here, we evaluate the radioligand in pigs and non-human primates (NHP). Furthermore, we investigate species differences in 5-HT7 R binding with [3 H]SB-269970 autoradiography in post mortem pig, NHP, and human brain tissue. Specific binding of [18 F]2FP3 was investigated by intravenous administration of the 5-HT7 R specific antagonist SB-269970. [3 H]SB-269970 autoradiography was performed as previously described. [18 F]2FP3 was synthesized in an overall yield of 35-45%. High brain uptake of the tracer was found in both pigs and NHPs, however pretreatment with SB-269970 only resulted in decreased binding of 20% in the thalamus, a 5-HT7 R rich region. Autoradiography on post mortem pig, NHP and human tissues revealed that specific binding of [3 H]SB-269970 was comparable in the thalamus of pig and NHP. Despite the high uptake of [18 F]2FP3 in both species, the binding could only be blocked to a limited degree with the 5-HT7 R antagonists. We speculate that the affinity of the radioligand is too low for imaging the 5-HT7 Rs in vivo and that part of the PET signal arises from targets other than the 5-HT7 R.